Kevin Dean Vassily
Analyst · ROTH Capital Partners
Thanks, Lawrence. We are pleased to report our third fiscal quarter of 2021. Net revenues for the quarter were $13.1 million, which was higher than the initial projection that we laid out in our S-1 for our IPO, and that we communicated during the IPO road show. That projection was $12.25 million at the midpoint of the range that we had provided. We exited the quarter with good momentum, thanks to 2 factors.
First, some of the supply chain stresses that we started seeing in December 2020, mainly on shipping times across Pacific, and congestion in the ports in Los Angeles started to ease. This allowed us to access more product from our suppliers to meet demand.
Second, we completed a convertible note financing ahead of our IPO, and we were able to immediately use the proceeds of that called prime to pump with some of our key suppliers. As a result, the month of March was a very strong sales month for us in absolute dollar terms and one of the better month in our company's history.
Sales growth of our in-house branded products remained strong as a percent of our total sales in the quarter. Our in-house brands made up 68% of sales, which was similar to the 2/3 of sales we saw for in-house brands in the second half of calendar year 2020.
From a channel perspective, approximately 88% of sales went through our e-commerce channels, which includes our third-party channel partners as well as our own in-house captive channel, zenhydro.com. This was a little higher than what we saw in the second half of calendar year 2020, where we saw approximately 85% of our sales run through e-commerce channels.
Sales mix had a favorable impact on gross margin in the quarter. Gross margins were 43.9% as compared to 32.3% in the same quarter last year. While sales mix between in-house brands and third-party products that we sell is the largest variable in our gross margin, there are other factors that can move the needle as well. This quarter, our ability to push larger manufacturing runs with some of our suppliers and to ship in larger quantities helped us.
Input costs can also be a factor, and I imagine we'll get some questions about this later. But in this quarter, completed March 31, input costs did not materially impact margins.
And then finally, the mix of products sold within our in-house brand category can have an impact. So product type, product age, volumes, in-stock availability, all these things have impact. In this quarter, these factors all aligned favorably.
Selling, general and administrative expense increased to $4.97 million in the quarter compared to $2.82 million in the same quarter last year. The increase was primarily due to an increase in sales volume, increases in cost in preparation to go public and investments in staff and programs, including marketing programs to support our longer-term growth strategy. This includes work on overhauling our captive e-commerce platforms at zenhydro.com.
The biggest increase was in G&A, which increased to 19.5% of net sales from 11.8% of net sales in the prior quarter -- or prior year quarter, excuse me. Over time, the G&A line will be the expense line where we expect to be able to generate some operating leverage. Given our third-party e-commerce channel strategy, selling costs are going to scale more or less linearly with sales volumes over the next couple of years until we can bring more of our volumes up on our captive channel.
Income from operations increased to approximately $788,000 from approximately $340,000 in the same quarter last year, with an increase of 131%. This was above the initial estimate of income from operations growth that we provided in our S-1, and on our IPO road show, of an increase between 87% and 125% over the prior year quarter. The increase was driven by increased sales volume, and the increase over our initial estimate was driven by higher-than-forecasted sales volume. As a percent of net sales, income from operations was 6% in the quarter.
As a note, we do not provide non-GAAP results or financials for comparison purposes. In particular, we don't provide an adjusted EBITDA metric that some others in our peer group provide. We do think that income from operations is an okay approximation for that metric, at least for now, largely because, historically, we've had very little DNA in the traditional sense and have not historically had many noncash or onetime charges. However, in this quarter, we do have some noncash charges, and I'll walk you through some of those that show up in our other income and expense line.
Other net expense in the quarter was made up of interest expense, financing fees, and other nonoperating income expenses that totaled $718,000 in the quarter. That was up from $33,000 in the same quarter last year. There are 2 onetime noncash items of note in this quarter: first, a net gain of $175,000 in nonoperating income from the forgiveness of a PPP loan that we secured during the pandemic; second, a nonoperating expense of $812,434 pertaining to our convertible note offering that we did in January of 2021. It consists of debt discount amortization and a charge -- sorry, a change in fair value of the conversion feature and warrant liabilities associated with this convertible offering. Without these 2 items, other net expense would have been approximately $97,000 in the quarter, which was made up of interest expense and financing charges.
Income before taxes was $30,990. Provision for income taxes was $237,813. And the net loss for the quarter was $206,823 for a fully diluted loss of $0.01 per share. If you back out the onetime noncash items, our income before taxes would have been approximately $691,000. Net income would have been $502,774 for a fully diluted EPS of $0.02 per share. And this compares to EPS of $0.01 per share in the same quarter last year.
Moving on to the balance sheet. As of March 31, we had net cash and equivalents of $474,000, approximately $4.6 million in net working capital. We only have $470,000 of long-term debt on the balance sheet in the form of an SBA loan. From a cash flow perspective, we used approximately $500,000 in cash in the quarter to fund investment into our supply chain.
After the end of the quarter, we completed our IPO and received $16.5 million in net proceeds. And we've also begun a process to secure a revolving credit facility. So we are now operating in a significantly improved liquidity position.
And then finally, before we take questions, I want to provide at least some commentary on how we plan to provide guidance on a go-forward basis. Our plan as a company, at least for the foreseeable future, is to provide annual targets at the beginning of our fiscal year. So we'll start that process with our fiscal year 2022, which will begin after June 30 of this year, and we'll provide those targets when we report our fiscal Q4 2021 results.
We're an e-commerce company. We're still small. We've got a significant amount of business that is conducted business-to-consumer. And sometimes that does make near-term visibility, sometimes difficult. However, I would like to provide at least some color around the full year 2021, given that we are most of the way through the year at this point.
What we are comfortable saying is that the order momentum we saw in March carried over to the months of April and May, and this was without the benefit of any incremental investment of our IPO proceeds into our supply chain. We are only now beginning to see that impact take hold. We believe the overall environment remains quite robust for hydroponics, and the tailwinds that Lawrence referenced earlier in his prepared remarks remain in place.
We're quite happy with where the business stands right now as we approach to the end of the fiscal year.
So that concludes our prepared remarks, and we are now happy to answer any questions that you might have. So operator, please open the line for any questions.